Transparency in DTC | GenomeWeb

Transparency in DTC

Direct-to-consumer genetic testing companies should be transparent about how they come to their risk predictions so that the consumers understand the usefulness of those predictions, says Daniel MacArthur at Genetic Future while drawing from a post by PHG's Caroline Wright. DTC testing shouldn't be banned nor should people have to go through their doctors for such services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.